Ensysce Biosciences reported cash from operations of -$1.87M and free cash flow of -$1.87M for the quarter ended Sep 2025, down 82.9% year over year. This cash flow statement covers 31 quarters of results from Mar 2018 through Sep 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||
| Net Income | 0.02M | -0.91M | -0.96M | -17.20M | -10.04M | -0.95M | -7.92M | -9.86M | -5.48M | -2.19M | -2.24M | -2.69M | -3.50M | -3.12M | -1.97M | 0.66M | -3.56M | -1.95M | -1.73M | -3.73M | |||||||||||
| Depreciation and DepletionDep. & Depletion | 52.00 | 51.00 | 50.00 | 50.00 | |||||||||||||||||||||||||||
| Share-based CompensationStock Comp. | 0.06M | 0.04M | 0.04M | 0.02M | 0.02M | 1.74M | -1.00 | 3.00 | 0.12M | 0.08M | 0.06M | 0.63M | 0.03M | 0.03M | 0.02M | 0.03M | 0.02M | 0.19M | -0.05M | ||||||||||||
| Deferred Taxes | -0.06M | ||||||||||||||||||||||||||||||
| Gains from Sales and DivestituresGains Divest | 0.00M | ||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -0.53M | -0.52M | -0.13M | -3.82M | -3.77M | -3.44M | -4.44M | -6.71M | -3.30M | -3.61M | -3.11M | -2.26M | -1.80M | -3.41M | -2.31M | -1.02M | -0.76M | -1.71M | -2.71M | -1.87M | |||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 52.00 | 51.00 | 50.00 | 50.00 | |||||||||||||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.02M | -0.09M | 0.44M | -1.60M | -0.17M | 0.66M | 2.09M | -1.76M | 1.66M | -1.35M | -0.32M | -0.36M | 0.79M | -1.30M | -0.50M | 1.74M | -0.52M | -0.74M | 0.43M | -0.58M | |||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.16M | 0.17M | 0.14M | 2.19M | -0.32M | 0.09M | 0.46M | 0.42M | 0.05M | -0.05M | -0.99M | -0.03M | -0.22M | -0.13M | -0.04M | 0.04M | 0.18M | 0.39M | -0.04M | 0.36M | |||||||||||
| Change in TaxesChange Taxes | |||||||||||||||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | 0.11M | 0.03M | |||||||||||||||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.00M | ||||||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 183.41M | -0.06M | 0.00M | ||||||||||||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.61M | 7.85M | 2.66M | 9.19M | -0.39M | -0.27M | 7.48M | 1.94M | 1.87M | 5.52M | -0.10M | 1.46M | 5.69M | -0.05M | 4.13M | 0.11M | 1.26M | 1.87M | 1.45M | ||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -0.39M | 0.26M | 7.54M | -1.18M | 2.69M | 6.36M | 2.08M | 0.36M | 1.10M | 1.00 | 0.79M | ||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||
| Change in Cash | -0.53M | 0.10M | 7.72M | -1.17M | 5.42M | -3.82M | -4.71M | 0.77M | -1.36M | -1.73M | 2.41M | -2.37M | -0.34M | 2.28M | -2.36M | 3.11M | -0.65M | -0.45M | -0.84M | -0.54M | |||||||||||
| Free Cash FlowFCF | -0.53M | -0.52M | -0.13M | -3.82M | -3.77M | -3.44M | -4.44M | -6.71M | -3.30M | -3.61M | -3.11M | -2.26M | -1.80M | -3.41M | -2.31M | -1.02M | -0.76M | -1.71M | -2.71M | -1.87M | |||||||||||
| Net Cash FlowNCF | 182.87M | 0.03M | 7.72M | -1.17M | 5.42M | -3.82M | -4.71M | 0.77M | -1.36M | -1.73M | 2.41M | -2.37M | -0.34M | 2.28M | -2.36M | 3.11M | -0.65M | -0.45M | -0.84M | -0.41M |
Pull Ensysce Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ENSC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ENSC", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ENSC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();